Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Anticancer Drugs. 2013 Jun;24(5):484–493. doi: 10.1097/CAD.0b013e32835ffdbb

Figure 1. Effect of EHMT2 inhibition on cell proliferation.

Figure 1

LA1-55n (A), IMR-5 (B) and NMB (C) cells were treated with BIX-01294 for 24 h at the concentration of 0.5, 1, 2.5, 5 and 10 μg/ml Proliferation was assessed by trypan blue exclusion to differentiate between dead and live cells. LA1-55n (D), IMR-5 (E) and NMB (F) cells were treated with BIX-01294 for 48 h at the concentration of 0.5, 1, 2.5, 5 and 10 μg/ml. Proliferation was assessed by trypan blue exclusion to differentiate between dead and live cells. * represents a statistical significance (p<0.01) in the difference between the vehicle- and BIX-01294-treated cells.